Literature DB >> 30654010

BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.

Wenyan Han1, Yiqun Zhang1, Cong Niu2, Jieyu Guo2, Jiajia Li1, Xiangxiang Wei2, Mengping Jia2, Xiuling Zhi3, Liangqing Yao4, Dan Meng5.   

Abstract

Transcriptional factor BTB and CNC homology 1 (Bach1) has been linked to tumor progression and metastasis, but the mechanisms underlying the effects of Bach1 on tumor growth and metastasis are largely uncharacterized. Here, we report that Bach1 expression was significantly higher in human epithelial ovarian cancer (EOC) tissues than in normal ovarian tissues and that higher levels of Bach1 were associated with tumor stage and poorer overall and progression-free survival. We found that Bach1 enhanced the expression of epithelial-mesenchymal transition (EMT) genes, including Slug and Snail, and promoted cell migration by recruiting HMGA2 in the human EOC cell line A2780. Bach1 overexpression enhanced and Bach1 knockout reduced the expression of Slug and the metastasis of EOC cells in a tumor metastasis mouse model. Bach1 expression was positively correlated with Slug and HMGA2 expression in human ovarian cancer tissues. In addition, Bach1 activated p-AKT and p-p70S6K, increased the expression of cyclin D1, and promoted the growth of ovarian cancer cells in vitro and tumor xenografts in vivo. Together, our findings reveal that Bach1 enhances tumor growth and recruits HMGA2 to promote EMT and ovarian cancer metastasis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bach1; Epithelial ovarian cancer metastasis; Epithelial-mesenchymal transition (EMT); HMGA2; Tumor growth

Year:  2019        PMID: 30654010     DOI: 10.1016/j.canlet.2019.01.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options.

Authors:  Samah Said Elbasateeny; Mahmoud Abdou Yassin; Mohamed Mahmoud Mokhtar; Adel Mohamed Ismail; Huda Fathy Ebian; Samia Hussein; Sherin Attia Shazly; Mai Mohammed Abdelwabab
Journal:  Int J Breast Cancer       Date:  2022-01-19

Review 2.  Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer.

Authors:  Abirami Arunachalam; Dinesh Kumar Lakshmanan; Guna Ravichandran; Soumi Paul; Sivakumar Manickam; Palanirajan Vijayaraj Kumar; Sivasudha Thilagar
Journal:  Med Oncol       Date:  2021-09-04       Impact factor: 3.064

3.  Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1.

Authors:  Hironari Nishizawa; Mitsuyo Matsumoto; Tomohiko Shindo; Daisuke Saigusa; Hiroki Kato; Katsushi Suzuki; Masaki Sato; Yusho Ishii; Hiroaki Shimokawa; Kazuhiko Igarashi
Journal:  J Biol Chem       Date:  2019-11-18       Impact factor: 5.157

4.  Localized EMT reprograms glial progenitors to promote spinal cord repair.

Authors:  Dana Klatt Shaw; Vishnu Muraleedharan Saraswathy; Lili Zhou; Anthony R McAdow; Brooke Burris; Emily Butka; Samantha A Morris; Sabine Dietmann; Mayssa H Mokalled
Journal:  Dev Cell       Date:  2021-02-19       Impact factor: 12.270

5.  Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion.

Authors:  Yang Yu; Chen Feng; Jian Kuang; Lixin Guo; Haixia Guan
Journal:  Endocrine       Date:  2022-01-20       Impact factor: 3.925

6.  BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression.

Authors:  Batya Cohen; Hanoch Tempelhof; Tal Raz; Roni Oren; Julian Nicenboim; Filip Bochner; Ron Even; Adam Jelinski; Raya Eilam; Shifra Ben-Dor; Yoseph Adaddi; Ofra Golani; Shlomi Lazar; Karina Yaniv; Michal Neeman
Journal:  Life Sci Alliance       Date:  2020-03-04

7.  A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma.

Authors:  Zhixiang Yu; Haiyan He; Yanan Chen; Qiuhe Ji; Min Sun
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.

Authors:  Mo Chen; Jia Zeng; Shuyi Chen; Jiajia Li; Huijie Wu; Xuhui Dong; Yuan Lei; Xiuling Zhi; Liangqing Yao
Journal:  Aging (Albany NY)       Date:  2020-06-08       Impact factor: 5.682

9.  Blocking long noncoding RNA MALAT1 restrained the development of laryngeal and hypopharyngeal carcinoma.

Authors:  Enhong Xu; Xiaoben Liang; Zhenhua Ji; Shuwei Zhao; Li Li; Juntian Lang
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-02       Impact factor: 2.503

10.  Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.

Authors:  Zihao Pan; Jiatong Lin; Duoguang Wu; Xiaotian He; Wenjian Wang; Xueting Hu; Lei Zhang; Minghui Wang
Journal:  Aging (Albany NY)       Date:  2019-12-26       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.